Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA
Ye Yuan, Jia Liu, Xiangnan Yu, Xingxin Liu, Yanni Cheng, Cheng Zhou, Mingyi Li, Lin Shi, Yan Deng, Huan Liu, Guobin Wang, Lin Wang, Zheng Wang
Topics & Concepts
DoxorubicinMultiple drug resistanceDrug resistanceCancer researchPharmacologyCancer cellEffluxDrugCD44Drug deliveryCancerChemistryChemotherapyMedicineBiologyCellBiochemistryInternal medicineOrganic chemistryMicrobiologyDrug Transport and Resistance MechanismsNanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery